Delfarmasp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2003-11-20
Share capital
250 000,00 PLN
Activity description

Delfarma specializes in parallel imports of medicines and offers lower-priced innovative drugs. It serves pharmacies, patients, hospitals and wholesalers, and develops its own brands.

Registered address
św. Teresy Od Dzieciątka Jezus 111, 91-222 Łódź, Poland
Website
delfarma.plWebsite active
Phone
Social media
Electronic delivery address
AE:PL-66942-13086-GUREV-30

Financials

Revenue history (in m)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 63.83mMedianUSD 874.80kAverageUSD 20.30m
Net profit
This companyUSD 819.97kMedianUSD 28.22kAverageUSD 816.54k
Operating costs
This companyUSD 60.88mMedianUSD 805.63kAverageUSD 19.09m
Assets
This companyUSD 22.34mMedianUSD 541.73kAverageUSD 10.95m

Bank accounts

Registered as a VAT taxpayer on 2003-12-01. Active

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Real estate

TypeAmount
Buildings and premises
PLN 8,478
Investment property
PLN 704.2K

MSiG notices

Publication dateEvent
Jun 7, 2010Merger registered
Mar 8, 2010Merger plan

Public aid

11 public aid cases recorded, with a total value of $1,159,926.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
$44,627
De minimis aid (in accordance with Commission Regulation 2023/2831)
$56,253
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$36,189

European Funds

ProjectEU co-financing
Zapobieganie negatywnych skutków Brexit w fimie Delfarma sp. z o.o.
$8,084

Tenders

1090 tenders recorded as contractor: 144 national ($2,397,739) and 946 EU ($2,127,258,904).

SubjectAmount
Dostawa leków dla Szpitala Wojewódzkiego im.dr. Ludwika Rydygiera w Suwałkach
–
Dostawa leków dla Szpitala Wojewódzkiego im.dr. Ludwika Rydygiera w Suwałkach
–
Dostawa leków dla Szpitala Wojewódzkiego im.dr. Ludwika Rydygiera w Suwałkach
–

Public sector contracts

Delfarma is the contractor in 288 public sector contracts, worth PLN 4.27m in total. They were signed with 90 public buyers.

Public buyerValue
Uniwersytecki Szpital Kliniczny Nr 4 w LubliniePLN 11,956
Uniwersytecki Szpital Kliniczny w PoznaniuPLN 3,195
Uniwersytecki Szpital Kliniczny w BiałymstokuPLN 900.00
Uniwersytecki Szpital Kliniczny w RadomskuPLN 450.00
Wojewódzki Szpital Specjalistyczny Im. Stefana Kardynała Wyszyńskiego Samodzielny Publiczny Zakład Opieki Zdrowotnej w LubliniePLN 3,300

Public procurement disputes (KIO)

Delfarma has been a party to 2 cases before the National Appeal Chamber (since 2020). It filed 1 appeal (1 dismissed). In 1 case it joined the proceedings as a participant.

DateCase no.RoleOther partyOutcome
Jan 23, 2024KIO 46/24Participant (on authority's side)Samodzielny Publiczny Szpital Kliniczny im. prof. Witolda OrłowskiegoDiscontinued
Dec 16, 2020KIO 3155/20AppellantWojewódzkie Centrum Terapii Uzależnień w GdańskuDismissed

Trademarks

Delfarma holds 73 active trademarks registered with the Polish Patent Office. 13 applications are pending. 6 marks have expired or were not registered. The first mark was filed in 2004.

MarkProtected until
Mezym(word)Dec 23, 2035
Sanoral(word)Oct 29, 2035
Aerolin(word)Jul 4, 2035
Medsamic(word)Jun 30, 2035
Felkarid(word)Jun 23, 2035

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Authorized Representatives

Dagmara Zawadowska Nowak – Attorney-in-fact (joint)
Tomasz Dzitko – President of the Management Board
Piotr Grzegorz Stolarczyk – Attorney-in-fact (joint)
Mariusz Jarosław Keller – Vice President of the Management Board
Róża Rochalska – Attorney-in-fact (joint)

Manner of representation

The following persons are authorised to submit declarations of will on behalf of the company: a) in the case of a one-person management board – the President of the Management Board independently; b) in the case of a multi-member management board – two members of the management board acting jointly, or one member of the management board jointly with a commercial proxy.

Supervisory board

Anna Gąsecka – Supervisory Board Member
Ryszard Błażejewski – Supervisory Board Member
Iwona Jadwiga Dzitko – Supervisory Board Member

Ownership

OwnerSharesShare valueStake
Konstantynów- Nieruchomości Sp. z o.o. Sp. K.
405$54,700.1681%
Yosemite Sp. z o.o. Sp. K.
95$12,830.9019%

Beneficial owners

Person

Competitors

Name
LubfarmS.A.
Medezinsp. z o.o.
Przedsiębiorstwo Zaopatrzenia Farmaceutyczno-Weterynaryjnego Centrowetsp. z o.o.
Magnapharm Polandsp. z o.o.
Chiesi Polandsp. z o.o.
BaylegS.A.
Perrigo Polandsp. z o.o.
SkamexS.A.
Dospirosp. z o.o.
Idalia Ludwikowscysp. j.

Change history

DateEvent
2015-03-17PKD change
2010-09-23PKD change
2010-08-04PKD change
2009-07-29Share capital change
2008-02-12Name change

FAQ

Last updated: 2026-07-16